Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

61 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Factors Associated With Prevalence and Treatment of Primary Biliary Cholangitis in United States Health Systems.
Lu M, Li J, Haller IV, Romanelli RJ, VanWormer JJ, Rodriguez CV, Raebel MA, Boscarino JA, Schmidt MA, Daida YG, Sahota A, Vincent J, Bowlus CL, Lindor K, Rupp LB, Gordon SC; FOLD Investigators. Lu M, et al. Among authors: haller iv. Clin Gastroenterol Hepatol. 2018 Aug;16(8):1333-1341.e6. doi: 10.1016/j.cgh.2017.10.018. Epub 2017 Oct 21. Clin Gastroenterol Hepatol. 2018. PMID: 29066370
Increasing Prevalence of Primary Biliary Cholangitis and Reduced Mortality With Treatment.
Lu M, Zhou Y, Haller IV, Romanelli RJ, VanWormer JJ, Rodriguez CV, Anderson H, Boscarino JA, Schmidt MA, Daida YG, Sahota A, Vincent J, Bowlus CL, Lindor K, Zhang T, Trudeau S, Li J, Rupp LB, Gordon SC; Fibrotic Liver Disease Consortium Investigators. Lu M, et al. Among authors: haller iv. Clin Gastroenterol Hepatol. 2018 Aug;16(8):1342-1350.e1. doi: 10.1016/j.cgh.2017.12.033. Epub 2017 Dec 23. Clin Gastroenterol Hepatol. 2018. PMID: 29277621
The prevalence of Healthcare Effectiveness Data and Information Set (HEDIS) initiation and engagement in treatment among patients with cannabis use disorders in 7 US health systems.
Lapham GT, Campbell CI, Yarborough BJH, Hechter RC, Ahmedani BK, Haller IV, Kline-Simon AH, Satre DD, Loree AM, Weisner C, Binswanger IA. Lapham GT, et al. Among authors: haller iv. Subst Abus. 2019;40(3):268-277. doi: 10.1080/08897077.2018.1544964. Epub 2019 Jan 18. Subst Abus. 2019. PMID: 30657438 Free PMC article.
Predictors of Healthcare Effectiveness Data and Information Set (HEDIS) treatment initiation and engagement among patients with opioid use disorder across 7 health systems.
Campbell CI, Weisner C, Binswanger IA, Lapham GT, Ahmedani BK, Yarborough BJH, Haller IV, Altschuler A, Hechter RC, Loree AM, Kline-Simon AH. Campbell CI, et al. Among authors: haller iv. Subst Abus. 2019;40(3):328-334. doi: 10.1080/08897077.2018.1545729. Epub 2019 Jan 24. Subst Abus. 2019. PMID: 30676931 Free PMC article.
Patient characteristics associated with treatment initiation and engagement among individuals diagnosed with alcohol and other drug use disorders in emergency department and primary care settings.
Kline-Simon AH, Stumbo SP, Campbell CI, Binswanger IA, Weisner C, Haller IV, Hechter RC, Ahmedani BK, Lapham GT, Loree AM, Sterling SA, Yarborough BJH. Kline-Simon AH, et al. Among authors: haller iv. Subst Abus. 2019;40(3):278-284. doi: 10.1080/08897077.2018.1547812. Epub 2019 Jan 31. Subst Abus. 2019. PMID: 30702983 Free PMC article.
Ursodeoxycholic Acid Treatment Preferentially Improves Overall Survival Among African Americans With Primary Biliary Cholangitis.
Gordon SC, Wu KH, Lindor K, Bowlus CL, Rodriguez CV, Anderson H, Boscarino JA, Trudeau S, Rupp LB, Haller IV, Romanelli RJ, VanWormer JJ, Schmidt MA, Daida YG, Sahota A, Vincent J, Zhang T, Li J, Lu M; FOLD Investigators. Gordon SC, et al. Among authors: haller iv. Am J Gastroenterol. 2020 Feb;115(2):262-270. doi: 10.14309/ajg.0000000000000512. Am J Gastroenterol. 2020. PMID: 31985529
Validity of an Automated Algorithm to Identify Cirrhosis Using Electronic Health Records in Patients with Primary Biliary Cholangitis.
Lu M, Bowlus CL, Lindor K, Rodriguez-Watson CV, Romanelli RJ, Haller IV, Anderson H, VanWormer JJ, Boscarino JA, Schmidt MA, Daida YG, Sahota A, Vincent J, Li J, Trudeau S, Rupp LB, Gordon SC; FOLD Investigators. Lu M, et al. Among authors: haller iv. Clin Epidemiol. 2020 Nov 10;12:1261-1267. doi: 10.2147/CLEP.S262558. eCollection 2020. Clin Epidemiol. 2020. PMID: 33204167 Free PMC article.
Dynamic Risk Prediction of Response to Ursodeoxycholic Acid Among Patients with Primary Biliary Cholangitis in the USA.
Li J, Lu M, Zhou Y, Bowlus CL, Lindor K, Rodriguez-Watson C, Romanelli RJ, Haller IV, Anderson H, VanWormer JJ, Boscarino JA, Schmidt MA, Daida YG, Sahota A, Vincent J, Wu KH, Trudeau S, Rupp LB, Melkonian C, Gordon SC; FOLD Investigators. Li J, et al. Among authors: haller iv. Dig Dis Sci. 2022 Aug;67(8):4170-4180. doi: 10.1007/s10620-021-07219-4. Epub 2021 Sep 9. Dig Dis Sci. 2022. PMID: 34499271
Development and implementation of a prescription opioid registry across diverse health systems.
Ray GT, Altschuler A, Karmali R, Binswanger I, Glanz JM, Clarke CL, Ahmedani B, Andrade SE, Boscarino JA, Clark RE, Haller IV, Hechter R, Roblin DW, Sanchez K, Yarborough BJ, Bailey SR, McCarty D, Stephens KA, Rosa CL, Rubinstein AL, Campbell CI. Ray GT, et al. Among authors: haller iv. JAMIA Open. 2022 May 17;5(2):ooac030. doi: 10.1093/jamiaopen/ooac030. eCollection 2022 Jul. JAMIA Open. 2022. PMID: 35651523 Free PMC article.
Prescription Opioid Dose Reductions and Potential Adverse Events: a Multi-site Observational Cohort Study in Diverse US Health Systems.
Metz VE, Ray GT, Palzes V, Binswanger I, Altschuler A, Karmali RN, Ahmedani BK, Andrade SE, Boscarino JA, Clark RE, Haller IV, Hechter RC, Roblin DW, Sanchez K, Bailey SR, McCarty D, Stephens KA, Rosa CL, Rubinstein AL, Campbell CI. Metz VE, et al. Among authors: haller iv. J Gen Intern Med. 2024 May;39(6):1002-1009. doi: 10.1007/s11606-023-08459-y. Epub 2023 Nov 6. J Gen Intern Med. 2024. PMID: 37930512
61 results